We're building a better ClinicalTrials.gov. Check it out and tell us what you think!

Key Record Dates

ClinicalTrials.gov Identifier: NCT04675333
Brief Title: Evorpacept (ALX148) in Combination With Pembrolizumab and Chemotherapy in Patients With Advanced Head and Neck Squamous Cell Carcinoma (ASPEN-04)

First Submitted : December 15, 2020
First Submitted that Met QC Criteria : December 17, 2020
First Posted : December 19, 2020

Last Update Submitted that Met QC Criteria : November 4, 2021
Last Update Posted : November 11, 2021